TuHURA Biosciences to present three posters on cancer immune suppression research at ASH
HURA•TuHURA Biosciences will present three posters on delta opioid receptor inhibition at the American Society of Hematology meeting on December 14, 2026. The research found inhibition reduced gene expression linked to myeloid-derived suppressor cell activity.
1. Research posters
TuHURA Biosciences will present three research posters on delta opioid receptor inhibition at the American Society of Hematology meeting on December 14, 2026. The findings show receptor inhibition reduces gene expression linked to myeloid-derived suppressor cell proliferation, migration and immune-suppressing activity. The research supports development of antibody-drug conjugates targeting immune-suppressing cells to address resistance to cancer immunotherapy.
